Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s40258-020-00632-2 http://scihub22266oqcxt.onion/10.1007/s40258-020-00632-2 33433853!7801567!33433853     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33433853&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Appl+Health+Econ+Health+Policy 2021 ; 19 (2): 181-190 Nephropedia Template TP {{tp|p=33433853|t=2021. How Many Intensive Care Beds are Justifiable for Hospital Pandemic Preparedness? A Cost-effectiveness Analysis for COVID-19 in Germany |pdf=|usr=}}{{33433853}} gab.com Text How Many Intensive Care Beds are Justifiable for Hospital Pandemic Preparedness A Cost-effectiveness Analysis for COVID-19 in Germany JO: Appl Health Econ Health Policy http://www.kidney.de/pget.php?&tw=1&pmid=33433853 #FOAvip INTRODUCTION: Germany is experiencing the second COVID-19 pandemic wave. The intensive care unit (ICU) bed capacity is an important consideration in the response to the pandemic. The purpose of this study was to determine the costs and benefits of maintaining or expanding a staffed ICU bed reserve capacity in Germany. METHODS: This study compared the provision of additional capacity to no intervention from a societal perspective. A decision model was developed using, e.g. information on age-specific fatality rates, ICU costs and outcomes, and the herd protection threshold. The net monetary benefit (NMB) was calculated based upon the willingness to pay for new medicines for the treatment of cancer, a condition with a similar disease burden in the near term. RESULTS: The marginal cost-effectiveness ratio (MCER) of the last bed added to the existing ICU capacity is euro21,958 per life-year gained assuming full bed utilization. The NMB decreases with an additional expansion but remains positive for utilization rates as low as 2%. In a sensitivity analysis, the variables with the highest impact on the MCER were the mortality rates in the ICU and after discharge. CONCLUSIONS: This article demonstrates the applicability of cost-effectiveness analysis to policies of hospital pandemic preparedness and response capacity strengthening. In Germany, the provision of a staffed ICU bed reserve capacity appears to be cost-effective even for a low probability of bed utilization. Twit Text FOAVip How Many Intensive Care Beds are Justifiable for Hospital Pandemic Preparedness A Cost-effectiveness Analysis for COVID-19 in Germany ????Appl Health Econ Health Policy http://www.kidney.de/pget.php?&tw=1&pmid=33433853 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33433853 #FOAvip English Wikipedia <ref>{{Cite pmid|33433853}}</ref> How Many Intensive Care Beds are Justifiable for Hospital Pandemic Preparedness? A Cost-effectiveness Analysis for COVID-19 in Germany #MMPMID33433853 Gandjour A Appl Health Econ Health Policy 2021[Mar]; 19 (2): 181-190 PMID33433853show ga INTRODUCTION: Germany is experiencing the second COVID-19 pandemic wave. The intensive care unit (ICU) bed capacity is an important consideration in the response to the pandemic. The purpose of this study was to determine the costs and benefits of maintaining or expanding a staffed ICU bed reserve capacity in Germany. METHODS: This study compared the provision of additional capacity to no intervention from a societal perspective. A decision model was developed using, e.g. information on age-specific fatality rates, ICU costs and outcomes, and the herd protection threshold. The net monetary benefit (NMB) was calculated based upon the willingness to pay for new medicines for the treatment of cancer, a condition with a similar disease burden in the near term. RESULTS: The marginal cost-effectiveness ratio (MCER) of the last bed added to the existing ICU capacity is euro21,958 per life-year gained assuming full bed utilization. The NMB decreases with an additional expansion but remains positive for utilization rates as low as 2%. In a sensitivity analysis, the variables with the highest impact on the MCER were the mortality rates in the ICU and after discharge. CONCLUSIONS: This article demonstrates the applicability of cost-effectiveness analysis to policies of hospital pandemic preparedness and response capacity strengthening. In Germany, the provision of a staffed ICU bed reserve capacity appears to be cost-effective even for a low probability of bed utilization. |*Planning Techniques[MESH] |Bed Occupancy/*economics[MESH] |COVID-19/*epidemiology[MESH] |Cost-Benefit Analysis[MESH] |Decision Support Techniques[MESH] |Germany/epidemiology[MESH] |Humans[MESH] |Intensive Care Units/*economics[MESH] |Pandemics[MESH]How Many Intensive Care Beds are Justifiable for Hospital Pandemic Pre(epmc).pdf DeepDyve Pubget Overpricing